SYNCRIP and eosinophilia-myalgia syndrome: This study represents the first systematic analysis of the molecular characteristics of MR in EMs, revealing that genes such as HSP90B1 and SYNCRIP are involved in the onset and progression of EMs by regulating metabolic pathways and the immune microenvironment.